T9G — Vidac Pharma Holding Balance Sheet
0.000.00%
Last trade - 00:00- €18.70m
- €18.67m
Annual balance sheet for Vidac Pharma Holding, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 0.123 | 0.034 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 0.037 | 0.008 |
| Total Current Assets | 0.16 | 0.042 |
| Net Property, Plant And Equipment | 0.005 | 0.005 |
| Other Long Term Assets | ||
| Total Assets | 0.172 | 0.047 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 0.283 | 0.795 |
| Long Term Debt | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | 0.283 | 0.795 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | -0.111 | -0.748 |
| Total Liabilities & Shareholders' Equity | 0.172 | 0.047 |
| Total Common Shares Outstanding |